Alveolar proteinosis is relatively serious, but with active and standardized treatment, patients can alleviate the symptoms of the disease, control its progression and prolong survival. Alveolar proteinosis is a relatively rare disease characterized by massive deposition of alveolar surface-active substances in the alveolar lumen. Patients may experience symptoms such as shortness of breath after progressive activity, cough, increased sputum, fever, and chest pain. Most patients with alveolar protein deposition disease can be relieved of their symptoms and control the progression of the disease with relevant treatment. Patients can be nebulized or subcutaneously injected with granulocyte-macrophage colony-stimulating factor under doctor’s guidance according to their own conditions, or take surgical treatments such as total lung lavage, transbronchoscopic segmental lung lavage, and so on. Some patients can resolve on their own, and the average survival rate of patients who underwent whole-lung lavage was significantly higher than that of those who did not. If patients are diagnosed with alveolar protein deposition, they need to go to regular hospitals in time and take relevant treatment measures under the guidance of doctors to avoid delaying the condition. In daily life, it is necessary to ensure sufficient rest and do not overwork.